Concord Medical Services (CCM) Competitors

Biodesix (NASDAQ:BDSX) and Concord Medical Services (NYSE:CCM) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, media sentiment, valuation, community ranking, risk and earnings.

Which has more risk and volatility, BDSX or CCM?

Biodesix has a beta of 1.17, suggesting that its share price is 17% more volatile than the S&P 500. Comparatively, Concord Medical Services has a beta of -0.64, suggesting that its share price is 164% less volatile than the S&P 500.

Does the media prefer BDSX or CCM?

In the previous week, Biodesix and Biodesix both had 5 articles in the media. Biodesix's average media sentiment score of 0.63 beat Concord Medical Services' score of -0.20 indicating that Biodesix is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Biodesix	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Concord Medical Services	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do institutionals & insiders hold more shares of BDSX or CCM?

21.0% of Biodesix shares are held by institutional investors. 69.2% of Biodesix shares are held by company insiders. Comparatively, 46.5% of Concord Medical Services shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Which has higher earnings & valuation, BDSX or CCM?

Concord Medical Services has higher revenue and earnings than Biodesix.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biodesix	$71.32M	1.07	-$52.15M	-$0.35	-1.49
Concord Medical Services	$471.70M	0.07	-$41.93M	N/A	N/A

Is BDSX or CCM more profitable?

Concord Medical Services has a net margin of 0.00% compared to Biodesix's net margin of -66.84%. Concord Medical Services' return on equity of 0.00% beat Biodesix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biodesix	-66.84%	-275.79%	-43.05%
Concord Medical Services	N/A	N/A	N/A

Do analysts rate BDSX or CCM?

Biodesix presently has a consensus target price of $2.86, indicating a potential upside of 446.85%. Given Biodesix's stronger consensus rating and higher possible upside, equities analysts clearly believe Biodesix is more favorable than Concord Medical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biodesix	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	3.00
Concord Medical Services	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Does the MarketBeat Community prefer BDSX or CCM?

Concord Medical Services received 166 more outperform votes than Biodesix when rated by MarketBeat users. However, 75.61% of users gave Biodesix an outperform vote while only 58.81% of users gave Concord Medical Services an outperform vote.

Company	Underperform	Outperform
Biodesix	Outperform Votes 31 75.61%	Underperform Votes 10 24.39%
Concord Medical Services	Outperform Votes 197 58.81%	Underperform Votes 138 41.19%

Summary

Biodesix beats Concord Medical Services on 9 of the 15 factors compared between the two stocks.